Clinical trials recruiting for Locally Advanced Pancreatic Adenocarcinoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
  NCT07157033 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment
  NCT06453486 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
  NCT07619313 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
  NCT06850623 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
  NCT04665947 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer
  NCT05524090 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
  NCT06673017 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma
  NCT06861452 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
  NCT04570943 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 9 locations
• Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC
  NCT06714604 · Phase: Phase 3 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
  NCT05679674 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
  NCT06998940 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 274 locations
• Surgery for Locally Unresectable Pancreatic Cancer
  NCT07241663 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
  NCT05356039 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
  NCT04172532 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 44 locations
• The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
  NCT06861088 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Related conditions

Trials recruiting for Locally Advanced Pancreatic Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Locally Advanced Pancreatic Adenocarcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.